Most Popular
-
1
Actor Jung Woo-sung admits to being father of model Moon Ga-bi’s child
-
2
Wealthy parents ditch Korean passports to get kids into international school
-
3
Man convicted after binge eating to avoid military service
-
4
First snow to fall in Seoul on Wednesday
-
5
Final push to forge UN treaty on plastic pollution set to begin in Busan
-
6
Korea to hold own memorial for forced labor victims, boycotting Japan’s
-
7
Nvidia CEO signals Samsung’s imminent shipment of AI chips
-
8
Industry experts predicts tough choices as NewJeans' ultimatum nears
-
9
Job creation lowest on record among under-30s
-
10
NK troops disguised as 'indigenous' people in Far East for combat against Ukraine: report
Yozma hints at US$100m funding for Korean biotech ventures
By Korea HeraldPublished : June 30, 2016 - 17:36
[THE INVESTOR] Yozma Group chairman Yigal Erlich on June 30 hinted at new funding worth up to US$100 million in Korea’s biotech venture firms.
The head of the leading venture capitalist based in Israel was visiting Seoul to attend a conference among bioscience experts and industry officials.
Touting Korea’s advanced medical techniques, he showed expectations about the growth potential of the nation’s biotech industry.
During his visit, Yozma Group also signed a memorandum of understanding with the Korea Bio Technology Organization to nurture some 1,000 biotech start-ups.
(theinvestor@heraldcorp.com)
-
Articles by Korea Herald
